The stock of Sempra (NYSE:SRE) last traded at $68.79, down -0.98% from the previous session.
SRE stock price is now -14.96% away from the 50-day moving average and -16.03% away from the 200-day moving average. The market capitalization of the company currently stands at $44.81B.
With the price target reduced from $96 to $77, Jefferies Downgraded its rating from Buy to Hold for Sempra (NYSE: SRE). On February 27, 2025, Barclays Downgraded its previous ‘Overweight’ rating to ‘Equal Weight’ on the stock reducing its target price from $95 to quote $72, while ‘UBS’ rates the stock as ‘Neutral’
In other news, MEARS MICHAEL N, Director bought 1,000 shares of the company’s stock on Mar 10 ’25. The stock was bought for $67,700 at an average price of $67.70. Upon completion of the transaction, the Director now directly owns 5,000 shares in the company, valued at $0.34 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 06 ’25, Director WARNER CYNTHIA J bought 700 shares of the business’s stock. A total of $49,455 was incurred on buying the stock at an average price of $70.65. This leaves the insider owning 8,759 shares of the company worth $0.6 million. A total of 0.07% of the company’s stock is owned by insiders.
During the past 12 months, Sempra has had a low of $64.89 and a high of $95.77. As of last week, the company has a debt-to-equity ratio of 1.16, a current ratio of 0.55, and a quick ratio of 0.49.
The net profit margin was 21.74% and return on equity was 9.55% for SRE. The company reported revenue of $3.76 billion for the quarter, compared to $3.49 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 7.65 percent.
